Archive for the ‘surgery retractions’ Category
A plastic surgery journal has retracted a paper after a researcher claimed it contained three figures without his permission.
According to Aesthetic Surgery Journal’s retraction notice (which is paywalled, tsk tsk), the figures were reproduced from a paper published in a Chinese journal without the original authors’ knowledge or permission: Read the rest of this entry »
In April 2015, a paper in the Journal of Medical Ethics welcomed the ban by the Chinese government as “a step in the right direction,” but noted that China remains plagued by a crucial shortage in available organs.
Some academics disagreed with the authors’ take on the issue, noting that the paper fails to note that many organs may continue to be harvested from Chinese prisoners of conscience; ultimately, the journal received a letter asking to retract the paper. The journal decided not to, and instead asked the authors to issue a lengthy correction, for instance changing the language about the government decision (“law” became“guideline”), and allowed critics to publish a rebuttal to the paper in May 2016. Read the rest of this entry »
So from time to time we’ll compile a list of retractions that appeared relatively straightforward, just for record-keeping purposes.
Often, these seemingly straightforward retractions involve duplications, in which authors — accidentally or on purpose — republish their own work elsewhere.
Sometimes journals and authors blame this event on “poor communication,” our first example notes:
JAMA has announced it does not intend to retract a 2005 review article about fetal pain, despite requests from anti-abortion activists who claim it has been misused in debates about the procedure.
Earlier this month, JAMA told one anti-abortion critic that it would take a look at the paper, which suggested that fetuses can’t feel pain before the third trimester. Critics have argued that newer findings have shown pain sensation appears earlier in gestation, yet the 2005 data continue to be cited in the discussion around abortion. What’s more, critics have lamented that some of the authors failed to mention their ties to the abortion industry.
But in a letter sent yesterday to James Agresti, Howard Bauchner, Editor in Chief at JAMA and The JAMA Network, writes: Read the rest of this entry »
The authors of a study about spinal fusion surgery have retracted it after realizing the cohort study was described as a prospective, randomized trial.
The last author told us he believed the incorrect wording was added to the paper — and the title — by accident. Even though he said the journal Spine suggested correcting it, the authors chose to retract the paper entirely.
The abstract of the study describes the design as a:
Prospective, randomized, controlled trial.
But according to the retraction notice for “Prospective, randomized, controlled trial of silicate-substituted calcium phosphate versus rhBMP-2 in a minimally invasive transforaminal lumbar interbody fusion,” the abstract was not accurate:
Pro-life activists have asked JAMA to retract a 2005 paper that suggested fetuses can’t feel pain before the third trimester.
Critics are arguing that newer findings have shown pain sensation appears earlier in gestation, yet the 2005 data continue to be cited in the discussion around abortion. What’s more, they note, some of the authors failed to mention their ties to the abortion industry.
The 2005 paper has been cited 191 times, according to Thomson Reuters Web of Science. We spoke with Howard Bauchner, Editor in Chief at JAMA and The JAMA Network, who told us something similar to what he said last week, when PETA asked to retract a paper they claim could be harmful to elephants: Read the rest of this entry »
When a researcher discovered one of the images in her papers was a duplication, she asked the journal to fix it — but the journal decided to retract the paper entirely.
The researcher, Suchitra Sumitran-Holgersson, is currently being investigated by the University of Gothenburg in Sweden after a number of her papers were questioned on PubPeer. She told us the duplication was the result of ‘‘genuine human error.’’ Tissue Engineering Part A, however, decided the request to swap the image was a ‘‘cause for concern,’’ and chose to retract the paper.
Here’s the retraction notice:
One paper examined whether the results of CT scans could be used to stage patients with uterine carcinoma; the other considered whether CT scans could be used to predict overall survival in uterine carcinoma. Both papers — by researchers at the Memorial Sloan Kettering Cancer Center — used data from the same 193 women. After they appeared in in different journals, the editors considered whether they were redundant — a quality that can spell retraction for a paper.
The editors explain why they decided the papers were unique in a brief commentary — a non-retraction notice, if you will — published in
a third journal, Abdominal Radiology:
Surgeon Paolo Macchiarini did not apply for the necessary ethics approval to perform the pioneering transplants he’s known for, according to the Swedish Research Council.
Chief Legal Counsel Anna Hörnlund, who wrote a letter in this week’s The Lancet, says Macchiarini’s work needed to obtain ethical approval from one of six regional ethical review boards, as required by Swedish law — and neither Macchiarini nor his former employer, Karolinska Institutet, did so:
The most recent notice mentions the investigation, and specifies that the first author, Satoshi Hagiwara, was responsible for the problematic figures in the paper. Hagiwara is also the first author on two retracted papers we reported on last year; one of the earlier retractions also mentions the investigation, but does not assign responsibility to any particular author. All three papers share three authors.
The retraction notice for “Continuous Hemodiafiltration Therapy Ameliorates LPS-Induced Systemic Inflammation in a Rat Model,” published in the Journal of Surgical Research, explains the issues with the paper: